Ehime University Hospital

Toon-shi, Ehime 791-0295

3 studies enrolling now · 10 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Alzheimer's Disease, Alzheimer's Disease Dementia, Anemia, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Lymphoma, Non-Hodgkin, Metastatic Non-Small Cell Lung Cancer, Mild Cognitive Impairment Due to Alzheimer's Disease, Myelofibrosis, Narcolepsy Type 2, Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) — Recruiting now
• A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib — Recruiting now
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial — Completed
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia — Stopped early
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early